BUDESONIDE INHALER MARKET ANALYSIS

Budesonide Inhaler Market, by Product Type (Inhalants and Nebulizer), by Dosage (Aerosols, Dry Powder, Suspension, and Sprays), by Strength (0.25mg, 0.5mg, and 1.0mg), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI2551
Pages :149
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

The side effect associated with budesonide inhaler
Product recall

Budesonide Inhaler Market Restraints

The major restraining factor for budesonide inhaler market growth is the side effects shown by budesonide such as

runny or stuffy nose,
sneezing,
coughing,
sore throat,
dry throat,
nosebleed,
nausea,
vomiting,
diarrhea,
stomach pain,
white patches or sores inside the mouth or on lips,
headache,
hoarseness,
voice changes,
Bad taste in the mouth

Moreover, product recall is the major factor which hinders the growth of global budesonide inhaler market over the forecast period. For instance, in September 2020, Perrigo Company plc, a Pharmaceutical company, announced a voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after halting production and distribution. The actions were been taken out of an abundance of caution as a result of complaints that some units may not dispense due to clogging. Perrigo's generic albuterol sulfate inhalation aerosol was developed in partnership with and manufactured by Catalent Pharma Solutions, a pharmaceutical company.